Lavender peppermint elequil aromatab for Quality of Life

UPMC Shadyside Hospital, Pittsburgh, PA

Targeting 2 different conditionsLavender peppermint elequil aromatab +1 moreN/AWaitlist AvailableLed by Jacques E Chelly, MDResearch Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Self-reported anxiety related to upcoming surgery

Be older than 18 years old

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Upday of surgery through one month post-operative

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will study the effects of lavender-peppermint aromatherapy on reducing post-operative anxiety, pain, and nausea in patients undergoing hip replacement surgery or mastectomy.

Eligible Conditions

Quality of Life
Anxiety

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You feel anxious about the surgery that will be performed on you.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day of surgery through one month post-operative

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day of surgery through one month post-operative

This trial's timeline: 3 weeks for screening, Varies for treatment, and day of surgery through one month post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in post-operative anxiety

Secondary outcome measures

Functional Recovery

Hospital Readmissions

Incidence of post-operative complications

+7 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Lavender Peppermint Elequil AromatabExperimental Treatment1 Intervention

Participants will have a lavender peppermint elequil aromatab applied in same day admissions area at least 1 hour prior to the start of unilateral hip replacement. Thereafter, the participant will apply a new treatment elequil aromatab at 24 hrs, 36 hrs, 48 hrs, and 60 hrs post-operative.

Group II: Sweet Almond Oil Elequil AromatabActive Control1 Intervention

Participants will have a sweet almond oil active comparator elequil aromatab applied in same day admissions area at least 1 hour prior to the start of unilateral hip replacement. Thereafter, the participant will apply a new active comparator elequil aromatab at 24 hrs, 36 hrs, 48 hrs, and 60 hrs post-operative.

0 / 1Eligibility criteria met

Find a site

Who is running the clinical trial?

University of PittsburghLead Sponsor

1,664 Previous Clinical Trials

16,297,573 Total Patients Enrolled

Beekley MedicalIndustry Sponsor

1 Previous Clinical Trials

100 Total Patients Enrolled

Jacques E Chelly, MDPrincipal Investigator

University of Pittsburgh

5 Previous Clinical Trials

199 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research experiment accept participants of all ages, particularly those below the age of 55?

"The requirements for enrolment in this trial involve being between 18 and 80 years of age. There is a separate 42-person cohort available to those under the legal minimum, while 220 participants over 65 are also sought after."

Answered by AI

How many individuals are being monitored for this medical exploration?

"Yes, according to the clinicaltrials.gov website, this investigation is currently enrolling patients. It was first announced on March 22nd 2021 and last edited February 22nd 2022. Sixty individuals are being sought at one location for participation in this trial."

Answered by AI

What are the fundamental goals of this experiment?

"As per the sponsor of this trial, Beekley Medical, its primary objective will be assessed during and post-operative period. This primary outcome is a change in post-operative anxiety levels. Secondary outcomes include Post-operative consequences of pain which is measured by PROMIS Pain Interference - Short Form 6b; Post-Operative emotional distress related to depression which is gauged with PROMIS Emotional Distress-Depression –Short form; and Post Operative pain rating using Visual Analog Scale (VAS). Each metric ranges from 0 to 10, where higher scores indicate more severe conditions respectively."

Answered by AI

Is enrollment available for this medical experiment at present?

"According to the records kept on clinicaltrials.gov, this medical research is still recruiting participants. The trial was launched in March 2021 and underwent its latest edit during February 2022."

Answered by AI

Do I fit the criteria necessary to join this medical research endeavor?

"This experiment seeks to enrol 60 individuals who suffer from anxiety, with ages ranging between 18 and 80 years of age. The essential criteria for inclusion is that all participants must have a self-reported fear of an impending surgical procedure, be willing/able to comply with the necessary follow-up measures, and either need to undergo unilateral hip replacement surgery or bilateral mastectomy operations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Aromatherapy for Improving Post-Surgical Quality of Life

Jacques E. Chelly 2021. "Aromatherapy for Improving Post-Surgical Quality of Life". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04800744.